Neurol. praxi. 2013;14(6):282-286

Mitochondrial syndromes with nervous system damage

MUDr.František Cibulčík, PhD.
Neurologická klinika LF SZU a UN Bratislava Ružinov

Diseases with nervous system involvement caused by impaired mitochondrial function include a wide range of types of inheritance,

damage to individual parts of the nervous system in combination with manifestations of dysfunction of other systems with high demands

for energy supply. The approach to classifying mitochondrial disease can be primarily based on the clinical presentation, the type of

biochemical damage, or the type of genetic damage. The paper describes mitochondrial disease syndromes, i.e. diseases whose phenotypic

presentation forms a coherent syndrome. Diagnosing these diseases, in addition to taking into account the history and clinical

presentation, involves genetic elucidation of the present defect as well as identification of changes at a microscopic and biochemical

level. Currently, no effective causal therapy is available in the vast majority of these conditions. Correct diagnosis, however, creates the

precondition for the use of effective treatment the perspective of which is in sight in the near future.

Keywords: mitochondria, encephalomyopathy, respiratory chain, maternal inheritance

Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cibulčík F. Mitochondrial syndromes with nervous system damage. Neurol. praxi. 2013;14(6):282-286.
Download citation

References

  1. Castro-Gago M, Alonso A, Pintos-Martinez E. Multiple systemic lipomatosis associated to polyneuropathy, atrophy of the cerebellum and mitochondrial cytopathy. Rev Neurol 2003; 36:1026-9. Go to original source...
  2. Cibulčík F, Špalek P, Lisý, Ľ.: Mitochondriálne myopatie s laktacidózou. Čes Slov Neurol Neurochir 1994; 57: 34-36.
  3. DiMauro S, Bonilla E, Lombes A, Shanske S, Minetti C, Toraes C. Mitochondrial encephalomyopathies. Neurol Clin 1990; 8: 483-506. Go to original source...
  4. Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand 2006; 114: 217-238. Go to original source... Go to PubMed...
  5. Garone C, Tadesse S, Hirano M. Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain 2011; 134: 3326-3332. Go to original source... Go to PubMed...
  6. Kissler JE, Whittaker RG, McFarland R: Mitochondrial diseases in childhood: a clinical approach to investigation and management. Developmental Medicine & Child Neurology 2010; 52: 422-433. Go to original source... Go to PubMed...
  7. Lev D, Yanoov-Sharav M, Watemberg N. White matter abnormalities in Leber's hereditary optic neuropathy due to the 3460 mitochondrial DNA mutation. Eur J Paediatr Neurol 2002; 6:121-3. Go to original source... Go to PubMed...
  8. McFarland R, Taylor RW, Turnbull DM. The neurology of mitochondrial DNA disease. Lancet Neurol 2002; 1: 343-51. Go to original source... Go to PubMed...
  9. McFarland R, Hudson G, Taylor RW. Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1). Arch Dis Child 2008; 93: 151-153. Go to original source... Go to PubMed...
  10. McFarland R, Turnbull DM. Batteries not incuded: diagnosis and management of mitochodnrial disease. J Int Med 2009; 265: 210-228. Go to original source... Go to PubMed...
  11. Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 2009; 11: 414-30. Go to original source... Go to PubMed...
  12. Parikh S. The neurologic manifestation of mitochodrial disease. Dev Disabil Res Rev 2010; 16: 120-128. Go to original source... Go to PubMed...
  13. Schapira AHV. The, ,new" mitochondrial disorders. J Neurol Neurosurg Psychiatry 2002; 72: 144-9. Go to original source... Go to PubMed...
  14. Schon EA, DiMauro S, Hirano M, Gilkerson RW. Therapeutic prospects for mitochondrial disease. Trends in Molecular Medicine 2010; 16: 268-276. Go to original source... Go to PubMed...
  15. Sproule D, Kaufman P. Mitochondrial encefalopathy, lactic acidosis and strokelike episodes. Ann N Y Acad Sci 2008; 1142: 133-158. Go to original source... Go to PubMed...
  16. Žigrai M, Staník J, Gašperíková D, Piesecká Ľ, Hrušovský Š, Klimeš I. Syndróm MELAS - literárny prehľad. Neurológia 2007; 2 (3): 173-177.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.